Jamie Samath sold $12M of ISRG
See Remarks at INTUITIVE SURGICAL INC. 23,172 shares at an average of $525.17, traded Nov 8, 2024, filed Nov 12, 2024.
Score components
- +15RoleOfficer
- +25Trade size$12.2M at market
- +20Share of holdings soldSold 73% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +1.4%, 3m +10.2%, 6m +5.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001610717-24-000519, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +3,007 | $290.33 | $873k | 11,764 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +2,352 | $347.42 | $817k | 14,116 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +2,352 | $245.60 | $578k | 16,468 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +1,515 | $242.34 | $367k | 17,983 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +1,521 | $177.99 | $271k | 19,504 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +1,449 | $166.62 | $241k | 20,953 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +1,449 | $182.83 | $265k | 22,402 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +432 | $174.26 | $75k | 22,834 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +432 | $139.52 | $60k | 23,266 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +2,694 | $304.67 | $821k | 25,960 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +2,693 | $229.39 | $618k | 28,653 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Common Stock10b5-1 | +3,007 | $208.90 | $628k | 31,660 | Nov 12, 2024 |
| Nov 8, 2024 | SOpen-market sale Common Stock10b5-1 | -22,903 | $525.00 | $12M | 8,757 | Nov 12, 2024 |
| Nov 11, 2024 | MOption exercise Common Stock10b5-1 | +134 | $304.67 | $41k | 8,891 | Nov 12, 2024 |
| Nov 11, 2024 | MOption exercise Common Stock10b5-1 | +135 | $229.39 | $31k | 9,026 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stock10b5-1 | -269 | $539.89 | $145k | 8,757 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -3,007 | $0.00 | $0 | 1,504 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -2,352 | $0.00 | $0 | 213 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -2,352 | $0.00 | $0 | 213 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,515 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,521 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,449 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,449 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -432 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -432 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -2,694 | $0.00 | $0 | 3,770 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -2,693 | $0.00 | $0 | 3,771 | Nov 12, 2024 |
| Nov 8, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -3,007 | $0.00 | $0 | 1,504 | Nov 12, 2024 |
| Nov 11, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -135 | $0.00 | $0 | 3,636 | Nov 12, 2024 |
| Nov 11, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -134 | $0.00 | $0 | 3,636 | Nov 12, 2024 |
Related signals
Other insiders at INTUITIVE SURGICAL INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 24Weak | INTUITIVE SURGICAL INC | Fredrik Widman VP Corporate Controller | $408k 1,089 shares | -69% | |
| 3Weak | INTUITIVE SURGICAL INC | Mark Brosius EVP & Chief Mfg and Supply Cha | $17k 48 shares | -6% | |
| 3Weak | INTUITIVE SURGICAL INC | Mark Brosius EVP & Chief Mfg and Supply Cha | $25k 69 shares | -8% | |
| 18Weak | INTUITIVE SURGICAL INC | Mark Brosius SVP & Chief Mfg and Supply Cha | $242k 431 shares | -32% | |
| 20Weak | INTUITIVE SURGICAL INC | Mark Brosius SVP & Chief Mfg and Supply Cha | $355k 645 shares | -33% | |
| 0Weak | INTUITIVE SURGICAL INC | Mark Brosius SVP & Chief Mfg and Supply Cha | $24k 42 shares | -2% | |
| 1Weak | INTUITIVE SURGICAL INC | Mark Brosius SVP & Chief Mfg and Supply Cha | $37k 66 shares | -3% | |
| 40Moderate | INTUITIVE SURGICAL INC | Robert DeSantis EVP & Chief Strategy & Corp Op | $5.8M 11,545 shares | -82% | |
| 40Moderate | INTUITIVE SURGICAL INC | Brian Edward Miller EVP & Chief Digital Officer | $6.4M 12,900 shares | -88% | |
| 28Weak | INTUITIVE SURGICAL INC | Mark Brosius SVP & Chief Mfg and Supply Cha | $261k 489 shares | -19% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.